Dr Marion Mafham
Marion Mafham
Clinical Research Fellow, CTSU
- Honorary Consultant Nephrologist, Oxford Kidney Unit
Marion Mafham studied medicine at the University of Edinburgh (1992-1998). In 2003, she joined the Renal Studies Group at CTSU for 3 years as a research fellow, working on the Study of Heart and Renal Protection. During this time she completed an MD thesis examining the relationship between measures of kidney function and cardiovascular risk factors and cardiovascular events. After completing her specialist training in Nephrology, she returned to CTSU in 2013, to work with Professor Jane Armitage in the Heart Studies Group. She is also an Honorary Consultant Nephrologist in the Oxford University Hospitals NHS trust.
Recent publications
-
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
-
Dexamethasone in Hospitalized Patients with Covid-19.
Journal article
RECOVERY Collaborative Group None. et al, (2021), N Engl J Med, 384, 693 - 704
-
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
Journal article
Morris EJA. et al, (2021), Lancet Gastroenterol Hepatol
-
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Horby P. et al, (2020)
-
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
RECOVERY Collaborative Group None., (2020), Lancet. 2020;396(10259):1345-52.